- Home
- RDHL vs GXAI Comparison
RDHL vs GXAI Comparison
Compare RDHL & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RDHL | GXAI |
|---|---|---|
| Founded | 2009 | 2021 |
| Country | Israel | United States |
| Employees | N/A | 3 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3M | 8.6M |
| IPO Year | 2012 | 2022 |
Fundamental Metrics
Financial Performance| Metric | RDHL | GXAI |
|---|---|---|
| Price | $0.57 | $0.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 252.0K |
| Earning Date | 04-27-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 71.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,933,030.00 |
| Revenue This Year | $381.91 | $271.23 |
| Revenue Next Year | N/A | $36.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 47901.74 |
| 52 Week Low | $0.54 | $0.59 |
| 52 Week High | $2.79 | $2.63 |
Technical Indicators
Market Signals| Indicator | RDHL | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 34.06 |
| Support Level | N/A | N/A |
| Resistance Level | $0.85 | $1.30 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 2.77 | 13.38 |
Price Performance
Historical ComparisonAbout RDHL Redhill Biopharma Ltd.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.